US$ 22.56
glp-1 vision loss drugs are associated with a 35% higher risk of NAION, an eye condition that can cause sudden loss. About 6 to 10 extra cases per 10,000 users over 3 years Blurry Vision from GLP-1 Medications:
Description
GLP-1Rs: Molecular Architecture, Central Distribution, and Intracellular Signaling The GLP-1R is a class B G protein-coupled receptor (GPCR) that mediates the diverse physiological effects of GLP-1 in both peripheral and central tissues [15]
doi: 10.1016/S2213-8587(15)00482-9 46 GasbjergLSBergmannNCStensenSChristensenMBRosenkildeMMHolstJJet al
Total blindness is uncommon, but vision deficits are often permanent

2021;106(2):E592-601
Adam Gilden, MD, MSCE Medical Reviewer Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Me...

Activating GLP-1R improves the brains ability to cope with stress by influencing neurotransmitter release and pathways involved in the stress response, which may help reduce cognitive and emotional issues related to aging